Global Pharmacovigilance and Drug Safety Software Market 2022-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Region: Trend Forecast and Growth Opportunity
- Report ID: 43102
- Date: Aug, 2022
- Pages: 173
- Category: Healthcare & Pharmaceuticals
Global pharmacovigilance and drug safety software market will reach $432.3 million by 2031, growing by 7.3% annually over 2022-2031, driven by the increasing prevalence of chronic diseases due to the aging population, the growing drug discovery pipelines, increase in incidence of adverse drug reactions (ADR), more stringent regulatory guidelines for drug safety, and the increasing adoption of AI and cloud technologies in PV software and solutions.
Highlighted with 82 tables and 92 figures, this 173-page report “Global Pharmacovigilance and Drug Safety Software Market 2022-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global pharmacovigilance and drug safety software market and all its sub-segments through extensively detailed classifications.
Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2022 and provides forecast from 2022 till 2031 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global pharmacovigilance and drug safety software market in every aspect of the classification from perspectives of Functionality, Clinical Phase, Method, Delivery Mode, Indication, End User, and Region.
Based on Functionality, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Adverse Event Reporting Software
• Drug Safety Audits Software
• Issue Tracking Software
• Fully Integrated Software
Based on Clinical Phase, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Pre-clinical
• Phase I
• Phase II
• Phase III
• Phase IV
By Method, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Spontaneous Reporting
• Intensified ADR Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• EHR Mining
By Delivery Mode, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• On-premise Delivery
• On-demand Delivery
By Indication, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Oncology
• Respiratory Disorders
• Cardiology
• Neurology
• Immunology
• Pain Management
• Other Indications
By End Users, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Business Process Outsourcing Firms (BPOs)
• Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE，Saudi Arabia， South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2031. The breakdown of all regional markets by country and split of each national market by Functionality, Delivery Mode and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Ab Cube
Accenture PLC
ArisGlobal LLC
Cognizant Technology Solutions Corporation
Ennov Solutions Inc.
Extedo GmbH
Honeywell International Inc. (Sparta Systems Inc.)
IQVIA Inc.
Max Application
Oracle Corporation
Sarjen Systems Pvt. Ltd.
United BioSource LLC
Veeva Systems Inc.
Wipro Limited
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 27
2.2 Major Growth Drivers 29
2.3 Market Restraints and Challenges 34
2.4 Emerging Opportunities and Market Trends 37
2.5 Porter’s Fiver Forces Analysis 41
3 Segmentation of Global Market by Functionality 45
3.1 Market Overview by Functionality 45
3.2 Adverse Event Reporting Software 47
3.3 Drug Safety Audits Software 48
3.4 Issue Tracking Software 49
3.5 Fully Integrated Software 50
4 Segmentation of Global Market by Clinical Phase 51
4.1 Market Overview by Clinical Phase 51
4.2 Pre-clinical 53
4.3 Phase I 54
4.4 Phase II 55
4.5 Phase III 56
4.6 Phase IV 57
5 Segmentation of Global Market by Method 58
5.1 Market Overview by Method 58
5.2 Spontaneous Reporting 60
5.3 Intensified ADR Reporting 61
5.4 Targeted Spontaneous Reporting 62
5.5 Cohort Event Monitoring 63
5.6 EHR Mining 64
6 Segmentation of Global Market by Delivery Mode 65
6.1 Market Overview by Delivery Mode 65
6.2 On-premise Delivery 67
6.3 On-demand Delivery 68
7 Segmentation of Global Market by Indication 69
7.1 Market Overview by Indication 69
7.2 Oncology 71
7.3 Respiratory Disorders 72
7.4 Cardiology 73
7.5 Neurology 74
7.6 Immunology 75
7.7 Pain Management 76
7.8 Other Indications 77
8 Segmentation of Global Market by End User 78
8.1 Market Overview by End User 78
8.2 Pharmaceutical and Biotechnology Companies 80
8.3 Contract Research Organizations (CROs) 81
8.4 Business Process Outsourcing Firms (BPOs) 82
8.5 Other End Users 83
9 Segmentation of Global Market by Region 84
9.1 Geographic Market Overview 2021-2031 84
9.2 North America Market 2021-2031 by Country 88
9.2.1 Overview of North America Market 88
9.2.2 U.S. 92
9.2.3 Canada 95
9.2.4 Mexico 97
9.3 European Market 2021-2031 by Country 99
9.3.1 Overview of European Market 99
9.3.2 Germany 103
9.3.3 U.K. 105
9.3.4 France 107
9.3.5 Spain 109
9.3.6 Italy 111
9.3.7 Netherlands 113
9.3.8 Rest of European Market 115
9.4 Asia-Pacific Market 2021-2031 by Country 117
9.4.1 Overview of Asia-Pacific Market 117
9.4.2 Japan 121
9.4.3 China 124
9.4.4 Australia 126
9.4.5 India 128
9.4.6 South Korea 130
9.4.7 Rest of APAC Region 132
9.5 South America Market 2021-2031 by Country 134
9.5.1 Argentina 137
9.5.2 Brazil 139
9.5.3 Chile 141
9.5.4 Rest of South America Market 143
9.6 MEA Market 2021-2031 by Country 144
9.6.1 UAE 147
9.6.2 Saudi Arabia 149
9.6.3 South Africa 151
9.6.4 Other National Markets 153
10 Competitive Landscape 154
10.1 Overview of Key Vendors 154
10.2 New Product Launch, Partnership, Investment, and M&A 157
10.3 Company Profiles 158
Ab Cube 158
Accenture PLC 160
ArisGlobal LLC 161
Cognizant Technology Solutions Corporation 162
Ennov Solutions Inc. 163
Extedo GmbH 164
Honeywell International Inc. (Sparta Systems Inc.) 165
IQVIA Inc. 166
Max Application 167
Oracle Corporation 168
Sarjen Systems Pvt. Ltd. 169
United BioSource LLC 170
Veeva Systems Inc. 171
Wipro Limited 172
RELATED REPORTS 173
List of Tables
Table 1. Snapshot of Global Pharmacovigilance and Drug Safety Software Market in Balanced Perspective, 2021-2031 20
Table 2. World Economic Outlook, 2021-2031 24
Table 3. World Economic Outlook, 2021-2023 25
Table 4. Main Product Trends and Market Opportunities in Global Pharmacovigilance and Drug Safety Software Market 37
Table 5. Global Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 45
Table 6. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase, 2021-2031, $ mn 51
Table 7. Global Pharmacovigilance and Drug Safety Software Market by Method, 2021-2031, $ mn 58
Table 8. Global Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 65
Table 9. Global Pharmacovigilance and Drug Safety Software Market by Indication, 2021-2031, $ mn 69
Table 10. Global Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 78
Table 11. Global Pharmacovigilance and Drug Safety Software Market by Region, 2021-2031, $ mn 85
Table 12. Leading National Pharmacovigilance and Drug Safety Software Market, 2021 and 2031, $ mn 87
Table 13. North America Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 90
Table 14. U.S. Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 94
Table 15. U.S. Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 94
Table 16. U.S. Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 94
Table 17. Canada Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 96
Table 18. Canada Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 96
Table 19. Canada Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 96
Table 20. Mexico Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 98
Table 21. Mexico Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 98
Table 22. Mexico Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 98
Table 23. Europe Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 102
Table 24. Germany Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 104
Table 25. Germany Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 104
Table 26. Germany Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 104
Table 27. U.K. Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 106
Table 28. U.K. Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 106
Table 29. U.K. Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 106
Table 30. France Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 108
Table 31. France Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 108
Table 32. France Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 108
Table 33. Spain Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 110
Table 34. Spain Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 110
Table 35. Spain Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 110
Table 36. Italy Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 112
Table 37. Italy Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 112
Table 38. Italy Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 112
Table 39. Netherlands Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 114
Table 40. Netherlands Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 114
Table 41. Netherlands Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 114
Table 42. Pharmacovigilance and Drug Safety Software Market in Rest of Europe by Country, 2021-2031, $ mn 116
Table 43. APAC Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 119
Table 44. Japan Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 123
Table 45. Japan Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 123
Table 46. Japan Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 123
Table 47. China Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 125
Table 48. China Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 125
Table 49. China Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 125
Table 50. Australia Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 127
Table 51. Australia Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 127
Table 52. Australia Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 127
Table 53. India Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 129
Table 54. India Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 129
Table 55. India Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 129
Table 56. South Korea Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 131
Table 57. South Korea Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 131
Table 58. South Korea Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 131
Table 59. Pharmacovigilance and Drug Safety Software Market in Rest of APAC by Country/Region, 2021-2031, $ mn 133
Table 60. South America Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 136
Table 61. Argentina Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 138
Table 62. Argentina Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 138
Table 63. Argentina Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 138
Table 64. Brazil Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 140
Table 65. Brazil Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 140
Table 66. Brazil Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 140
Table 67. Chile Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 142
Table 68. Chile Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 142
Table 69. Chile Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 142
Table 70. MEA Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 146
Table 71. UAE Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 148
Table 72. UAE Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 148
Table 73. UAE Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 148
Table 74. Saudi Arabia Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 150
Table 75. Saudi Arabia Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 150
Table 76. Saudi Arabia Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 150
Table 77. South Africa Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 152
Table 78. South Africa Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 152
Table 79. South Africa Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 152
Table 80. Ab Cube: Company Snapshot 158
Table 81. Ab Cube: Business Segmentation 159
Table 82. Ab Cube: Product Portfolio 159
List of Figures
Figure 1. Research Method Flow Chart 14
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 17
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 19
Figure 4. Global Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 22
Figure 5. Impact of COVID-19 on Business 27
Figure 6. Primary Drivers and Impact Factors of Global Pharmacovigilance and Drug Safety Software Market 29
Figure 7. Percentage of Trial Participants by Country, 2015-2019 32
Figure 8. World Drug Discovery Market, 2019-2030, $ mn 33
Figure 9. Primary Restraints and Impact Factors of Global Pharmacovigilance and Drug Safety Software Market 34
Figure 10. Investment Opportunity Analysis 38
Figure 11. Porter’s Fiver Forces Analysis of Global Pharmacovigilance and Drug Safety Software Market 41
Figure 12. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, % of Revenue 46
Figure 13. Global Addressable Market Cap in 2022-2031 by Functionality, Value ($ mn) and Share (%) 46
Figure 14. Global Pharmacovigilance and Drug Safety Software Market by Functionality: Adverse Event Reporting Software, 2021-2031, $ mn 47
Figure 15. Global Pharmacovigilance and Drug Safety Software Market by Functionality: Drug Safety Audits Software, 2021-2031, $ mn 48
Figure 16. Global Pharmacovigilance and Drug Safety Software Market by Functionality: Issue Tracking Software, 2021-2031, $ mn 49
Figure 17. Global Pharmacovigilance and Drug Safety Software Market by Functionality: Fully Integrated Software, 2021-2031, $ mn 50
Figure 18. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase, 2021-2031, % of Sales Revenue 52
Figure 19. Global Addressable Market Cap in 2022-2031 by Clinical Phase, Value ($ mn) and Share (%) 52
Figure 20. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Pre-clinical, 2021-2031, $ mn 53
Figure 21. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase I, 2021-2031, $ mn 54
Figure 22. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase II, 2021-2031, $ mn 55
Figure 23. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase III, 2021-2031, $ mn 56
Figure 24. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase IV, 2021-2031, $ mn 57
Figure 25. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Method, 2021-2031, % of Sales Revenue 59
Figure 26. Global Addressable Market Cap in 2022-2031 by Method, Value ($ mn) and Share (%) 59
Figure 27. Global Pharmacovigilance and Drug Safety Software Market by Method: Spontaneous Reporting, 2021-2031, $ mn 60
Figure 28. Global Pharmacovigilance and Drug Safety Software Market by Method: Intensified ADR Reporting, 2021-2031, $ mn 61
Figure 29. Global Pharmacovigilance and Drug Safety Software Market by Method: Targeted Spontaneous Reporting, 2021-2031, $ mn 62
Figure 30. Global Pharmacovigilance and Drug Safety Software Market by Method: Cohort Event Monitoring, 2021-2031, $ mn 63
Figure 31. Global Pharmacovigilance and Drug Safety Software Market by Method: EHR Mining, 2021-2031, $ mn 64
Figure 32. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, % of Revenue 66
Figure 33. Global Addressable Market Cap in 2022-2031 by Delivery Mode, Value ($ mn) and Share (%) 66
Figure 34. Global Pharmacovigilance and Drug Safety Software Market by Delivery Mode: On-premise Delivery, 2021-2031, $ mn 67
Figure 35. Global Pharmacovigilance and Drug Safety Software Market by Delivery Mode: On-demand Delivery, 2021-2031, $ mn 68
Figure 36. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Indication, 2021-2031, % of Revenue 70
Figure 37. Global Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%) 70
Figure 38. Global Pharmacovigilance and Drug Safety Software Market by Indication: Oncology, 2021-2031, $ mn 71
Figure 39. Global Pharmacovigilance and Drug Safety Software Market by Indication: Respiratory Disorders, 2021-2031, $ mn 72
Figure 40. Global Pharmacovigilance and Drug Safety Software Market by Indication: Cardiology, 2021-2031, $ mn 73
Figure 41. Global Pharmacovigilance and Drug Safety Software Market by Indication: Neurology, 2021-2031, $ mn 74
Figure 42. Global Pharmacovigilance and Drug Safety Software Market by Indication: Immunology, 2021-2031, $ mn 75
Figure 43. Global Pharmacovigilance and Drug Safety Software Market by Indication: Pain Management, 2021-2031, $ mn 76
Figure 44. Global Pharmacovigilance and Drug Safety Software Market by Indication: Other Indications, 2021-2031, $ mn 77
Figure 45. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, % of Revenue 78
Figure 46. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 79
Figure 47. Global Pharmacovigilance and Drug Safety Software Market by End User: Pharmaceutical and Biotechnology Companies, 2021-2031, $ mn 80
Figure 48. Global Pharmacovigilance and Drug Safety Software Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn 81
Figure 49. Global Pharmacovigilance and Drug Safety Software Market by End User: Business Process Outsourcing Firms (BPOs), 2021-2031, $ mn 82
Figure 50. Global Pharmacovigilance and Drug Safety Software Market by End User: Other End Users, 2021-2031, $ mn 83
Figure 51. Global Market Snapshot by Region 84
Figure 52. Geographic Spread of Worldwide Pharmacovigilance and Drug Safety Software Market, 2021-2031, % of Sales Revenue 85
Figure 53. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%) 86
Figure 54. North American Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 89
Figure 55. Breakdown of North America Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue 90
Figure 56. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 91
Figure 57. U.S. Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 93
Figure 58. Canada Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 95
Figure 59. Pharmacovigilance and Drug Safety Software Market in Mexico, 2021-2031, $ mn 97
Figure 60. European Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 100
Figure 61. Breakdown of European Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue 101
Figure 62. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 102
Figure 63. Pharmacovigilance and Drug Safety Software Market in Germany, 2021-2031, $ mn 103
Figure 64. Pharmacovigilance and Drug Safety Software Market in U.K., 2021-2031, $ mn 105
Figure 65. Pharmacovigilance and Drug Safety Software Market in France, 2021-2031, $ mn 107
Figure 66. Pharmacovigilance and Drug Safety Software Market in Spain, 2021-2031, $ mn 109
Figure 67. Pharmacovigilance and Drug Safety Software Market in Italy, 2021-2031, $ mn 111
Figure 68. Pharmacovigilance and Drug Safety Software Market in Netherlands, 2021-2031, $ mn 113
Figure 69. Pharmacovigilance and Drug Safety Software Market in Rest of Europe, 2021-2031, $ mn 115
Figure 70. Asia-Pacific Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 118
Figure 71. Breakdown of APAC Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue 118
Figure 72. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 120
Figure 73. Pharmacovigilance and Drug Safety Software Market in Japan, 2021-2031, $ mn 122
Figure 74. Pharmacovigilance and Drug Safety Software Market in China, 2021-2031, $ mn 124
Figure 75. Pharmacovigilance and Drug Safety Software Market in Australia, 2021-2031, $ mn 126
Figure 76. Pharmacovigilance and Drug Safety Software Market in India, 2021-2031, $ mn 128
Figure 77. Pharmacovigilance and Drug Safety Software Market in South Korea, 2021-2031, $ mn 130
Figure 78. Pharmacovigilance and Drug Safety Software Market in Rest of APAC, 2021-2031, $ mn 132
Figure 79. South America Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 135
Figure 80. Breakdown of South America Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue 135
Figure 81. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 136
Figure 82. Pharmacovigilance and Drug Safety Software Market in Argentina, 2021-2031, $ mn 137
Figure 83. Pharmacovigilance and Drug Safety Software Market in Brazil, 2021-2031, $ mn 139
Figure 84. Pharmacovigilance and Drug Safety Software Market in Chile, 2021-2031, $ mn 141
Figure 85. Pharmacovigilance and Drug Safety Software Market in Rest of South America, 2021-2031, $ mn 143
Figure 86. Pharmacovigilance and Drug Safety Software Market in Middle East and Africa (MEA), 2021-2031, $ mn 145
Figure 87. Breakdown of MEA Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue 145
Figure 88. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 146
Figure 89. Pharmacovigilance and Drug Safety Software Market in UAE, 2021-2031, $ mn 147
Figure 90. Pharmacovigilance and Drug Safety Software Market in Saudi Arabia, 2021-2031, $ mn 149
Figure 91. Pharmacovigilance and Drug Safety Software Market in South Africa, 2021-2031, $ mn 151
Figure 92. Growth Stage of Global Pharmacovigilance and Drug Safety Software Industry over the Forecast Period 154
Research methodology is mainly referring to the practical how of any offered piece of research. More specifically, it’s all about how a researcher systematically designs a study in order to assure extremely valid as well as reliable results that ultimately address the targets and objectives of the research.
In any formal research including academic journal, article, dissertation and so on, there will be a special section on a research methodology that mainly describes what, by whom, how to gather as well as how to evaluate the data are provided.
This research methodology has been segmented into following types:
Primary Research:
It is said to be original information that the researchers collect for the crucial purposes of answering the research questions of readers with the help of surveys, observations and experiments.
Secondary Research:
The secondary research is the data that has already been collected by various other researchers in the form of government analysis or scientific studies.
Qualitative Research:
It is descriptive and subjective method irrespective of facts. Both observation and description are essential in this type of research methodology. Its main vision is to analyze knowledge, attitudes, behaviours as well as opinions of people related to the topic of any research. This method has been operated through grounded research, case study and actionable research.
Quantitative Research:
It contains several laboratory experiments, basic surveys, mathematical calculations, simulations and so on. The possible measurement, quantity or amount is considered to be a major factor in the quantitative research methodology.
Clients
